TBRG1 and breast cancer: To test the clinical application potential of TB‐5, we used two types of 60‐core tissue arrays (CS01, CS02), containing 63 BC cases and 57 normal bladder cases in total, with Cy5‐labeled TB‐5 or Cy5‐labeled libraries, respectively.